SITAGLIPTIN/STADA F.C.TAB 50MG/TAB Kreeka - kreeka - Εθνικός Οργανισμός Φαρμάκων

sitagliptin/stada f.c.tab 50mg/tab

stada arzneimittel ag, germany stadastrasse 2 - 18, 61118 bad vilbel - sitagliptin hydrochloride monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 50mg/tab - sitagliptin hydrochloride monohydrate 56,688mg - sitagliptin

SITAGLIPTIN/STADA F.C.TAB 100MG/TAB Kreeka - kreeka - Εθνικός Οργανισμός Φαρμάκων

sitagliptin/stada f.c.tab 100mg/tab

stada arzneimittel ag, germany stadastrasse 2 - 18, 61118 bad vilbel - sitagliptin hydrochloride monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 100mg/tab - sitagliptin hydrochloride monohydrate 113,376mg - sitagliptin

SITAGLIPTIN/STADA F.C.TAB 25MG/TAB Kreeka - kreeka - Εθνικός Οργανισμός Φαρμάκων

sitagliptin/stada f.c.tab 25mg/tab

stada arzneimittel ag, germany stadastrasse 2 - 18, 61118 bad vilbel - sitagliptin hydrochloride monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 25mg/tab - sitagliptin hydrochloride monohydrate 28,344mg - sitagliptin

Kinpeygo Euroopa Liit - kreeka - EMA (European Medicines Agency)

kinpeygo

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, εντερική αντιφλεγμονώδη / antiinfective πράκτορες - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.

Ximluci Euroopa Liit - kreeka - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Οφθαλμολογικά - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

FINGOLIMOD/STADA CAPS 0.5MG/CAP Kreeka - kreeka - Εθνικός Οργανισμός Φαρμάκων

fingolimod/stada caps 0.5mg/cap

stada arzneimittel ag, germany stadastrasse 2 - 18, 61118 bad vilbel - fingolimod hydrochloride - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 0.5mg/cap - fingolimod hydrochloride 0,56mg - fingolimod

SUGAMMADEX/STADA INJ.SOL 100MG/ML Kreeka - kreeka - Εθνικός Οργανισμός Φαρμάκων

sugammadex/stada inj.sol 100mg/ml

stada arzneimittel ag, germany stadastrasse 2 - 18, 61118 bad vilbel - sugammadex sodium - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 100mg/ml - sugammadex sodium 108,8mg - sugammadex